|
|
 |
| |
|
Home > Drug Companies > Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc.
Every year, thousands of people face the stresses and anxieties, not to mention the physical difficulties, of having a medical condition or illness. At Ferring, They have the opportunity to help some of those people. That is the reason why they are excited to come to work in the morning, and why they are passionate about what they do.
Ferring Pharmaceuticals Inc. products closely resemble those found naturally in the body to minimize undesirable side-effects, and to help achieve desired results with low doses. Traditionally, Ferring has concentrated its research on modifying posterior pituitary hormones to develop new peptide-based pharmaceuticals, but recent years have led to work with other substances such as GnRH-analogues, enzyme inhibitors, and oxytocin receptor blockers.
There are a lot of pharmaceutical companies out there that are bigger than they are but none are more dedicated to who they serve. They like to think of ourselves as a patient advocacy company. That means they believe in meeting patients' needs by providing them with educational resources, ongoing support, and highly effective, quality products provided at a reasonable price.
They don't tell doctors how to practice medicine. They simply present them with the facts and let the data speak for itself. At Ferring, their approach to business is central to who they are. They care about people and that's what drives the work they do.
Ferring Pharmaceuticals Inc. US division is a research-based biopharmaceutical company that offers treatments for patients with infertility and osteoarthritis of the knee. Ferring produces and markets a family of once-daily infertility treatments, including the foundation of mixed protocol, Menopurmenoptropins for injection, USP, and its perfect partner, Bravelle urofollitropin for injection, purified. Also, Ferring introduced Euflexxa, the first bioengineered injectable hyaluronic acid approved in the US for the treatment of osteoarthritis of the knee. Founded in 1951, their parent company Ferring BV is a research-driven specialty pharmaceutical company active in global markets.
Back to Drug Companies
|
|
|
|
|
|
|
|